Tissue Markers Predictive of Early Stenosis in the Arterovenous Fistula for Hemodialysis
IRCCS Azienda Ospedaliero-Universitaria di Bologna
150 participants
Mar 18, 2020
INTERVENTIONAL
Conditions
Summary
The study involves the recruitment of two populations. POPULATION 1 (surgical sample of excess venous segment): at least 75 consecutive patients, enrolled according to the inclusion criteria and subjected to first AVF surgery as part of the normal care pathway, at the Metropolitan Vascular Surgery Unit, Dir. Prof. Mauro Gargiulo of the S.Orsola-Malpighi University Hospital. POPULATION 2 (surgical sample of arterialized venous segment from removal of previous AVF): at least 75 consecutive patients, enrolled according to the inclusion criteria and subjected to reoperation for correction of complication and/or new AVF by proximalization, as part of the normal care pathway, at the Metropolitan Vascular Surgery Unit, Dir. Prof. Mauro Gargiulo of the S.Orsola-Malpighi University Hospital.
Eligibility
Inclusion Criteria3
- Age greater than or equal to 18 years;
- Patients candidates for first AVF for hemodialysis or correction of AVF complication, as part of the normal care pathway;
- Obtaining informed consent signed by the patient
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Primary objective 1. Identify any predictive or favoring tissue markers of early stenosis in AVF for hemodialysis. Secondary objectives 2. Compare the results on the possible different expression of tissue markers before and during dialysis. 3. Compare the results on the possible different expression of tissue markers between AVFs made with portions of cephalic vein and AVFs made with portions of basilic vein, in order to evaluate whether the different topographic origin of the AVF can influence its duration.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06815159